171 related articles for article (PubMed ID: 18804048)
1. Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation.
Sundin M; Lindblom A; Örvell C; Barrett AJ; Sundberg B; Watz E; Wikman A; Broliden K; Le Blanc K
Biol Blood Marrow Transplant; 2008 Oct; 14(10):1172-1179. PubMed ID: 18804048
[TBL] [Abstract][Full Text] [Related]
2. Non-Permissive Parvovirus B19 Infection: A Reservoir and Questionable Safety Concern in Mesenchymal Stem Cells.
Bua G; Marrazzo P; Manaresi E; Gamberini C; Bonsi L; Alviano F; Gallinella G
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175911
[TBL] [Abstract][Full Text] [Related]
3. Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction.
Rollín R; Alvarez-Lafuente R; Marco F; Jover JA; Hernández-García C; Rodríguez-Navas C; López-Durán L; Fernández-Gutiérrez B
Osteoarthritis Cartilage; 2007 Apr; 15(4):475-8. PubMed ID: 17207644
[TBL] [Abstract][Full Text] [Related]
4. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow.
Watanabe K; Otabe K; Shimizu N; Komori K; Mizuno M; Katano H; Koga H; Sekiya I
Stem Cell Res Ther; 2018 Mar; 9(1):80. PubMed ID: 29587847
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Pro-inflammatory Cytokine Genes by Parvovirus B19 in Human Bone Marrow Mesenchymal Stem Cells.
Amiri S; Atashi A; Azad M; Elmi A; Abbaszade Dibavar M; Ajami M; Ajami M; Rassaei N; Mohammadihaji R; Gheibi N
Biochem Genet; 2020 Feb; 58(1):63-73. PubMed ID: 31250332
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009.
Kooistra K; Mesman HJ; de Waal M; Koppelman MH; Zaaijer HL
Vox Sang; 2011 Apr; 100(3):261-6. PubMed ID: 20946549
[TBL] [Abstract][Full Text] [Related]
8. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
9. Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation.
Wasak-Szulkowska E; Grabarczyk P; Rzepecki P
Transpl Infect Dis; 2008 Jun; 10(3):201-5. PubMed ID: 17631000
[TBL] [Abstract][Full Text] [Related]
10. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
Cassinotti P; Siegl G; Michel BA; Brühlmann P
J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
[TBL] [Abstract][Full Text] [Related]
11. Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products.
Plentz A; Hahn J; Knöll A; Holler E; Jilg W; Modrow S
Transfusion; 2005 Nov; 45(11):1811-5. PubMed ID: 16271109
[TBL] [Abstract][Full Text] [Related]
12. Persistence of human parvovirus B19 in human tissues.
Söderlund-Venermo M; Hokynar K; Nieminen J; Rautakorpi H; Hedman K
Pathol Biol (Paris); 2002 Jun; 50(5):307-16. PubMed ID: 12116849
[TBL] [Abstract][Full Text] [Related]
13. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).
Brown KE; Hibbs JR; Gallinella G; Anderson SM; Lehman ED; McCarthy P; Young NS
N Engl J Med; 1994 Apr; 330(17):1192-6. PubMed ID: 8139629
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.
Zadsar M; Aghakhani A; Banifazl M; Kazemimanesh M; Tabatabaei Yazdi SM; Mamishi S; Bavand A; Sadat Larijani M; Ramezani A
J Med Virol; 2018 Aug; 90(8):1318-1322. PubMed ID: 29663448
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of human parvovirus B19 in hospital workers.
Miyamoto K; Ogami M; Takahashi Y; Mori T; Akimoto S; Terashita H; Terashita T
J Hosp Infect; 2000 Jul; 45(3):238-41. PubMed ID: 10896805
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow.
Lundqvist A; Tolfvenstam T; Bostic J; Söderlund M; Broliden K
Scand J Infect Dis; 1999; 31(1):11-6. PubMed ID: 10381211
[TBL] [Abstract][Full Text] [Related]
17. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis.
Zakrzewska K; Azzi A; De Biasi E; Radossi P; De Santis R; Davoli PG; Tagariello G
J Med Virol; 2001 Oct; 65(2):402-7. PubMed ID: 11536251
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte P antigen: cellular receptor for B19 parvovirus.
Brown KE; Anderson SM; Young NS
Science; 1993 Oct; 262(5130):114-7. PubMed ID: 8211117
[TBL] [Abstract][Full Text] [Related]
19. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus B19 viraemia in Dutch blood donors.
Zaaijer HL; Koppelman MH; Farrington CP
Epidemiol Infect; 2004 Dec; 132(6):1161-6. PubMed ID: 15635975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
